Missed Vaccines & Measles: Why Kids Fall Behind on Shots

The resurgence of measles in the U.S., already at a three-decade high with over 2,000 cases reported in 2025, isn’t simply a matter of increased exposure. A new study published in JAMA Network Open reveals a critical vulnerability in vaccination efforts: delays in initial vaccine doses at 2 months dramatically increase the likelihood of children missing crucial vaccinations, including the MMR shot, by age 2. This isn’t just about parental hesitancy; it’s about a narrowing window for pediatricians to effectively intervene and a concerning trend of complete vaccine refusal, exacerbated by eroding trust in public health institutions.

For decades, the CDC’s recommended vaccination schedule has been a cornerstone of public health, successfully controlling and even eliminating diseases like measles. However, the study, leveraging data from over 322,000 children, highlights a disturbing shift. While previous research established a link between delayed vaccinations and lower overall coverage, this study pinpoints the 2-month visit as a pivotal moment. The initial series of vaccinations – protecting against hepatitis B, rotavirus, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, and pneumococcal disease – appears to act as a gateway. If that initial step is missed, the likelihood of completing the full schedule plummets.

This trend coincides with a broader decline in public trust in health authorities, fueled by misinformation surrounding COVID-19 and, more recently, the controversial overhaul of the CDC’s vaccine advisory committee by Health Secretary Robert F. Kennedy Jr. The removal of independent experts and their replacement with individuals known for vaccine skepticism has undoubtedly contributed to an environment of uncertainty and distrust. The recent decision to alter the long-standing recommendation for universal hepatitis B vaccination at birth – now limited to infants of mothers with known exposure – further exemplifies this shift and is likely to fuel further debate and potentially, further delays.

The Forward Look

The implications of this study extend beyond measles. A decline in adherence to the recommended vaccination schedule threatens to unravel decades of progress in controlling preventable diseases. We can anticipate several key developments in the coming months:

• Increased Scrutiny of CDC Policy: Kennedy Jr.’s continued reshaping of the CDC’s vaccination policies will face mounting criticism from the medical community and public health advocates. Expect legal challenges and increased pressure for transparency.
• Pediatrician Protocol Changes: Pediatric practices will likely adapt their protocols to prioritize early engagement with parents, focusing on building trust and addressing vaccine concerns *before* the 2-month visit. This may involve pre-appointment phone calls, educational materials, and dedicated time for Q&A.
• Data-Driven Interventions: Health systems will increasingly leverage data analytics – like that provided by Truveta – to identify at-risk populations and target interventions to improve vaccination rates.
• Potential for Localized Outbreaks: Without a concerted effort to reverse these trends, we can expect to see more localized outbreaks of vaccine-preventable diseases, placing a strain on healthcare resources and potentially leading to serious complications, particularly among vulnerable populations.

The study’s authors are already considering analyzing the impact of the recent hepatitis B vaccine policy changes. This is a critical next step, as it will provide valuable insights into whether these changes further exacerbate the trend of vaccine hesitancy and delay. The window for intervention is closing, and a proactive, data-driven, and trust-building approach is essential to protect public health.